Ashland Inc. logo

Ashland Inc.

ASH

NYSEBasic MaterialsChemicals - Specialty

Regular session

$73.37

+$0.705 · +0.97%

Aug 24, 10:19 AM ET

ASH company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

45

Fair Value

Momentum

53

Neutral

Sentiment

61

Bullish

Risk resilience

75

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.

Industry
Chemicals - Specialty
Sector
Basic Materials
Headquarters
US
CEO
Guillermo Novo
Listed since
Mar 17, 1980
Employees
2,900

Market position

Day range

Current $73.37

52-week range

Current $73.37

Open
$72.98
Previous close
$72.665
Volume
39.89K
0.04× average
Average volume
942.04K
Average daily volume
Market cap
3.36B USD
Beta
0.39
Market reference 1
50-day average
$68.7724
+6.69% above average
200-day average
$60.0407
+22.20% above average

Financials

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends47%13%-21%-55%Gross margin, FY2021: 31.74%Gross margin, FY2022: 34.71%Gross margin, FY2023: 30.49%Gross margin, FY2024: 29.25%Gross margin, FY2025: 30.10%Operating margin, FY2021: 9.10%Operating margin, FY2022: 13.93%Operating margin, FY2023: 7.85%Operating margin, FY2024: -1.23%Operating margin, FY2025: -42.49%Net margin, FY2021: 10.42%Net margin, FY2022: 38.77%Net margin, FY2023: 8.12%Net margin, FY2024: 8.00%Net margin, FY2025: -46.33%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 31.74%. Gross margin FY2022 34.71%. Gross margin FY2023 30.49%. Gross margin FY2024 29.25%. Gross margin FY2025 30.10%. Operating margin FY2021 9.10%. Operating margin FY2022 13.93%. Operating margin FY2023 7.85%. Operating margin FY2024 -1.23%. Operating margin FY2025 -42.49%. Net margin FY2021 10.42%. Net margin FY2022 38.77%. Net margin FY2023 8.12%. Net margin FY2024 8.00%. Net margin FY2025 -46.33%.

Income trends

Revenue

1.82B USD-13.68%

Operating income

−775M USD-2880.77%

Net income

−845M USD−1.01B USD
Income trends across reported periods2.71B USD1.42B USD125.8M USD−1.17B USDRevenue, FY2021: 2.11B USDRevenue, FY2022: 2.39B USDRevenue, FY2023: 2.19B USDRevenue, FY2024: 2.11B USDRevenue, FY2025: 1.82B USDOperating income, FY2021: 192M USDOperating income, FY2022: 333M USDOperating income, FY2023: 172M USDOperating income, FY2024: −26M USDOperating income, FY2025: −775M USDNet income, FY2021: 220M USDNet income, FY2022: 927M USDNet income, FY2023: 178M USDNet income, FY2024: 169M USDNet income, FY2025: −845M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 2.11B USD. Revenue FY2022 2.39B USD. Revenue FY2023 2.19B USD. Revenue FY2024 2.11B USD. Revenue FY2025 1.82B USD. Operating income FY2021 192M USD. Operating income FY2022 333M USD. Operating income FY2023 172M USD. Operating income FY2024 −26M USD. Operating income FY2025 −775M USD. Net income FY2021 220M USD. Net income FY2022 927M USD. Net income FY2023 178M USD. Net income FY2024 169M USD. Net income FY2025 −845M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue1.82B USD2.11B USD2.19B USD2.39B USD2.11B USD
Cost of goods sold1.28B USD1.5B USD1.52B USD1.56B USD1.44B USD
Gross profit549M USD618M USD668M USD830M USD670M USD
Research and development54M USD55M USD51M USD55M USD50M USD
Selling, general, and administrative345M USD404M USD365M USD393M USD358M USD
Operating expenses1.32B USD644M USD496M USD497M USD478M USD
Interest income5M USD10M USD12M USD4M USD1M USD
Interest expense63M USD53M USD57M USD66M USD73M USD
Depreciation and amortization237M USD274M USD243M USD241M USD244M USD
Operating income−775M USD−26M USD172M USD333M USD192M USD
Net income−845M USD169M USD178M USD927M USD220M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$78.71

7.28% upside
Past 12 months12-month forecastHigh $85.00Average $78.71Low $75.00

Recent analyst actions

11 institutions
Morgan StanleymaintainEqual Weight

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$1.65

2025 complete year+40.4% since 2021

2026 partial: $0.835

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 1, 2026

$0.42

Quarterly

Record Sep 1, 2026 · Payment Sep 15, 2026

Dividend

Ex-dividend Jun 1, 2026

$0.42

Quarterly

Record Jun 1, 2026 · Payment Jun 15, 2026

Dividend

Ex-dividend Feb 27, 2026

$0.415

Quarterly

Record Mar 1, 2026 · Payment Mar 15, 2026

Dividend

Ex-dividend Dec 1, 2025

$0.415

Quarterly

Record Dec 1, 2025 · Payment Dec 15, 2025

Dividend

Ex-dividend Aug 29, 2025

$0.415

Quarterly

Record Sep 1, 2025 · Payment Sep 15, 2025

Dividend

Ex-dividend May 30, 2025

$0.415

Quarterly

Record Jun 1, 2025 · Payment Jun 15, 2025

ASH peers

ETFs holding ASH

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research ASH

research.disclaimer